We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Serotonin Receptor Is Reduced in Panic Disorder

By Biotechdaily staff writers
Posted on 02 Feb 2004
Brain scans have revealed to researchers that in patients with panic disorder, a type of serontonin receptor is reduced by almost one-third in three structures straddling the center of the brain. More...
The findings were reported in the January 21, 2004, issue of the Journal of Neuroscience.

In the current study, researchers used positron emission tomography (PET) scans to visualize serotonin receptors in brain areas of interest in 16 panic disorder patients, seven of whom also suffered from major depression, and 15 matching controls. A radioactive tracer binds to the receptors, revealing their location and a numerical count by brain region. Subjects also underwent structural magnetic resonance imaging (MRI) scans, which were overlaid with their PET scans to precisely match it with brain structure. The new finding of serotonin receptor reduction is the first to show that the receptor may be abnormal in the disorder and may help to explain how genes might influence vulnerability. Genes, for example, might increase risk for the disorder by coding for decreased expression of the receptors.

In a related study, recent experiments with knockout mice showed that a popular serotonin selective reuptake inhibitor (SSRI) drug produces its anti-anxiety effects by stimulating the formation of new neurons in the hippocampus via the serotonin receptor.

The study was conducted by Drs. Alexander Neumeister and Wayne Drevets and colleagues, of the U.S. National Institute of Mental Health (NIMH, Bethesda, MD, USA).




Related Links:
NIMH

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.